Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

How India's Torrent Is Building Resilience In Brazil

This article was originally published in Scrip

Executive Summary

Torrent Pharmaceuticals reported a strong set of numbers for the third quarter ended December 2015, despite turbulence in markets like Brazil, where it has done some sharp "belt tightening", and remains "bullish" long term.


Related Content

Torrent On Course For Buy, US Momentum